Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

Evaluating how well and how safely Alisertib works with hormone therapy in treating patients with breast cancer that has come back or spread… Recruiting

2024-511497-79-00 Hormone receptor positive (HR+), human epidermal growth 2024-12-30
Safety and efficacy of low-dose interleukin-2 therapy in chronic inflammatory barrier diseases (IL-2-ID) Recruiting

2023-510297-14-00 Primary Sclerosing Cholangitis (PSC) 2024-12-27
Studying the effects of deferiprone in Pelizaeus-Merzbacher disease Recruiting

2024-511968-81-00 Pelizaeus-Merzbacher disease 2024-12-27
A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 65 years with alcohol-re… Recruiting

2024-511596-15-00 Liver Diseases, Alcoholic 2024-12-26
HPV2-2303 - Phase 2 clinical trial evaluating secondary HPV vaccination after treatment of high-grade cervical lesions Recruiting

2024-513081-19-00 high-grade cervical intraepithelial lesions 2024-12-24
Permanence of Indocyanine Green in axillary lymph nodes three weeks after subdermal injection in patients with Breast Carcinoma and metastat… Recruiting

2024-513163-57-00 Breast Cancer 2024-12-20
BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PATIENTS WITH ARVD.BRAVE Recruiting

2023-505048-20-00 Arrhythmogenic right ventricular dysplasia 2024-12-20
To compare cilastatin vs thiosulfatein renal protection in patients undergoing debulking surgery with intraoperative hyperthermic intraperit… Recruiting

2024-518854-18-00 acute kidney injury 2024-12-19
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 2024-12-18
Randomized phase 2 study of Valproic acid combinEd with rechallenge anti-EGFR based regimen regimens in pretreated patients with RAS/BRAF wi… Recruiting

2024-514420-16-00 RAS/BRAF wild-type metastatic colorectal cancer 2024-12-18
Pasireotide as Maintenance Treatment with monthly deep intramuscular injection in SSTR2/3/5-Expressing Synovial Sarcoma and Desmoplastic Sma… Recruiting

2024-511935-86-00 Locally advanced or metastatic synovial sarcoma ICD-O3, 2024-12-18
Study of the effectiveness of drugs selected depending on the molecular profile of diffuse intrinsic pontine glioma (DIPG). Recruiting

2024-515952-19-00 diffuse intrinsic pontine glioma 2024-12-18
A Phase 2 diagnostic study with 68Ga-EVG321 in Patients with Small Cell Lung Cancer Recruiting

2024-514584-25-00 Small Cell Lung Cancer 2024-12-16
[18F]Fluoride PET-CT in psoriasis patients at risk for developing psoriatic arthritis Recruiting

2024-514759-13-01 Psoriasis 2024-12-16
Partial or total removal of the pancreas and transplantation of the patient's own islet cells in patients with pancreatic cancer and a high … Recruiting

2023-507773-17-00 Patients with perampullary carcinoma and a high-risk pr 2024-12-11
A Phase 2 study to Evaluate the Safety, Tolerability and Efficacy of Efgartigimod PH20 SC given by prefilled syringe in Kidney Transplant Re… Recruiting

2023-508180-72-00 Antibody-Mediated Rejection 2024-12-11
A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k… Recruiting

2023-510150-17-00 Active, refractory systemic lupus erythematosus (SLE), 2024-12-11
Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study Recruiting

2024-513145-36-00 Sudden sensori neural hearing loss 2024-12-11
Phase II study evaluating the addition of elacestrant, an oral selective estrogen receptor degrader (SERD), to standard-of-care olaparib in … Recruiting

2023-504925-38-00 patients with hormone receptor (HR)-positive, HER2-nega 2024-12-10
Safety of Trifluridine/tipiracil in patients with dihydropyrimidine dehydrogenase deficiency diagnosed with metastatic colorectal or gastroe… Recruiting

2023-508724-35-00 Patients with pMMR/MSS metastatic adenocarcinoma of the 2024-12-10
A Phase-2b, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Enc… Recruiting

2023-504686-23-00 anti-N-methyl-D-aspartate receptor encephalitis (anti-N 2024-12-10
A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc) Recruiting

2023-510380-34-00 Diffuse cutaneous systemic sclerosis (dcSSc) 2024-12-10
Efficacy and Safety of Navepegritide in Adolescents with Achondroplasia Recruiting

2024-514208-15-00 Achondroplasia in Children and Adolescents 2024-12-10
Abatacept for therapy of IgG4-related disease Recruiting

2024-512863-30-00 IgG4-related disease 2024-12-09